[{"NetIncomeLossConverted_1_Q2_USD":-49301000.0,"NetIncomeLossConverted_2_Q2_USD":-89943000.0,"StockholdersEquityConverted_0_Q2_USD":693310000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-95458000.0,"CommonStockSharesOutstanding_0_Q2_shares":140663755.0,"StockholdersEquity_0_Q2_USD":693181000.0,"EarningsPerShareBasic_1_Q2_USD":-0.35,"EarningsPerShareBasic_2_Q2_USD":-0.64,"RevenuesConverted_1_Q2_USD":38505000.0,"RevenuesConverted_2_Q2_USD":76947000.0,"Assets_0_Q2_USD":1033374000.0,"CommonStockSharesConverted_0_Q2_shares":140663755.0,"Ticker":"ADPT","CIK":"1478320","name":"ADAPTIVE BIOTECHNOLOGIES CORP","OfficialName":"Adaptive Biotechnologies Corporation Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1463975665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]